Colonoscopy versus Fecal Immunochemical Testing in Colorectal-Cancer Screening
Top Cited Papers
- 23 February 2012
- journal article
- research article
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 366 (8), 697-706
- https://doi.org/10.1056/nejmoa1108895
Abstract
Colonoscopy and fecal immunochemical testing (FIT) are accepted strategies for colorectal-cancer screening in the average-risk population.Keywords
This publication has 36 references indexed in Scilit:
- Long-Term Risk of Colorectal Cancer After Negative ColonoscopyJournal of Clinical Oncology, 2011
- Protection From Colorectal Cancer After ColonoscopyAnnals of Internal Medicine, 2011
- Colorectal Cancer Screening for Average-Risk North Americans: An Economic EvaluationPLoS Medicine, 2010
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trialThe Lancet, 2010
- Low Risk of Colorectal Cancer and Advanced Adenomas More Than 10 Years After Negative ColonoscopyGastroenterology, 2010
- Association of Colonoscopy and Death From Colorectal CancerAnnals of Internal Medicine, 2009
- Cochrane Systematic Review of Colorectal Cancer Screening Using the Fecal Occult Blood Test (Hemoccult): An UpdateThe American Journal of Gastroenterology, 2008
- Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline From the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of RadiologyGastroenterology, 2008
- The Effect of Fecal Occult-Blood Screening on the Incidence of Colorectal CancerThe New England Journal of Medicine, 2000